Investors / China / FreeS Fund
FreeS Fund
Venture capital · Shanghai, China · Asia Pacific
FreeS Fund is a fund management company founded in 2015 that invests in startups and supports their growth. It focuses on early-stage investments while also participating in growth-stage and mid-to-late stage opportunities, and provides portfolio services such as business development, finance, legal, HR, PR and FA.
Invests inHealthcare & BiotechAI & Machine LearningRobotics & Hardware
In its own wordsartificial intelligenceconsumertmtbiotechsmart manufacturingnew energy
Your fit with FreeS Fund
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsFreeS Fund lists 25 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (22%), AI & Machine Learning (22%) and Robotics & Hardware (16%). 83% of its companies are based in China. It invests most often alongside MSA Capital, SoftBank Vision Fund and General Atlantic.
Counts come from funding rounds that name FreeS Fund, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not FreeS Fund's whole history. Rounds on record name 1 company; its own site lists 25. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 100% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 60th | 25 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 22th | 22% in its largest sector |
| Reach | 42th | 2 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 22% | 15% |
| AI & Machine Learning | 22% | 18% |
| Robotics & Hardware | 16% | 1% |
| Industrial & Manufacturing | 9% | 7% |
| Consumer | 6% | 3% |
| Real Estate & Construction | 3% | 3% |
| Enterprise Software | 3% | 8% |
| Gaming | 3% | 1% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| MSA Capital | 3 |
| SoftBank Vision Fund | 3 |
| General Atlantic | 2 |
| Gobi Partners | 2 |
| 11.2 Capital | 1 |
| 137 Ventures | 1 |
| 408 Ventures | 1 |
| 5Y Capital | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2496%
- No longer answers00%
- Points to another company14%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare FreeS Fund head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with FreeS Fund| Date | Company | Stage |
|---|---|---|
| 18 Dec 2025 | Series A |
Round details for FreeS Fund
Amounts, full round histories and every co-investor in FreeS Fund's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
25 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
Fintech | Portfolio page | |||
| Portfolio page | ||||
| Corenetic develops and manufactures robotic systems for tasks such as nucleic acid extraction and cell toxicity detection | Robotics & Hardware | Portfolio page | ||
| Portfolio page | ||||
| Coyote Bioscience develops and provides molecular diagnostic instruments and reagents for various applications, including infectious disease detection and genetic testing. | Healthcare & Biotech | Portfolio page | ||
| Deepkinase provides services related to proteomics, genomics, and drug discovery and development. | Healthcare & Biotech | Portfolio page | ||
| Infiscale-tech builds next-generation intelligent computing systems based on the TPU route | AI & Machine LearningSpace & Defense | Portfolio page | ||
| The company develops and manufactures micro-precision motion components and servo control technologies for industries such as robotics, biomedical, and automation. | Robotics & HardwareIndustrial & Manufacturing | Portfolio page | ||
| The company develops and sells various types of robots, including humanoid robots and robotic systems. | Robotics & Hardware | Portfolio page | ||
| The company develops and manufactures precision motion and measurement systems for various applications, including low-temperature and high-magnetic field environments. | Industrial & ManufacturingAI & Machine Learning | Portfolio page | ||
| Portfolio page | ||||
| NextVPU develops a spatial intelligent computing platform for smart devices to perceive and understand the world | AI & Machine LearningRobotics & Hardware | Portfolio page | ||
| PatPat sells clothing, particularly pajamas and sleepwear, for adults, children, and babies. | E-commerce & MarketplacesConsumer | Portfolio page | ||
| Pyrotech Therapeutics treats human diseases through precision modulation of innate immunity. | Healthcare & Biotech | Portfolio page | ||
| Rezubio develops drugs using a membrane-anchored drug design platform | Healthcare & Biotech | Dec 2025Series A | Funding round | |
| Portfolio page | ||||
| The company sells coffee products | Food & Agriculture | Portfolio page | ||
| Cider sells women's fashion clothing. | Consumer | Portfolio page | ||
| Singleron Biotechnologies provides single cell sequencing solutions and products | Healthcare & Biotech | Portfolio page | ||
| The company develops and applies acoustic AI technology to various fields, including industry, energy, and healthcare. | AI & Machine LearningHealthcare & Biotech | Portfolio page |
About this data
site last read 10 Nov 2026- Site
- freesvc.com
- Last read
- 10 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 18 Dec 2025
- Companies checked
- 25
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get FreeS Fund's profile as data
Pull FreeS Fund's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/freesvc.com
# also
GET /v1/firms/freesvc.com/portfolio
GET /v1/firms/freesvc.com/coinvestors
GET /v1/firms/freesvc.com/news